Sarina  Tanimoto net worth and biography

Sarina Tanimoto Biography and Net Worth

Chief Medical Officer of ARS Pharmaceuticals

Sarina Tanimoto, M.D., M.B.A., is our co-founder and has served as our Chief Medical Officer since 2018, a position she has functionally served in since 2015. From 2015 to 2018, Dr. Tanimoto served as a member of our Board of Directors. Dr. Tanimoto previously served as Chief Medical Officer of Pacific-Link Regulatory Consulting and Research, Inc., a medicinal product development consultancy, where she supported multiple programs from Phase 1 to Phase 3 clinical trials in various therapeutic areas, including several intranasal products. Prior to Pacific-Link Regulatory Consulting and Research, Inc., Dr. Tanimoto held roles in clinical and business development during her tenure at AnGes Inc., a biopharmaceutical company, and also served as a clinical scientist at Roche, a research healthcare company, where she was involved in global clinical development. Dr. Tanimoto earned an M.D. from University of Toyama, followed by internal medicine training at the National Center for Global Health and Medicine in Tokyo. She holds an M.B.A. from McGill University.

What is Sarina Tanimoto's net worth?

The estimated net worth of Sarina Tanimoto is at least $13.72 million as of December 17th, 2024. Dr. Tanimoto owns 1,098,499 shares of ARS Pharmaceuticals stock worth more than $13,720,253 as of March 29th. This net worth evaluation does not reflect any other assets that Dr. Tanimoto may own. Additionally, Dr. Tanimoto receives an annual salary of $2,470,000.00 as Chief Medical Officer at ARS Pharmaceuticals. Learn More about Sarina Tanimoto's net worth.

How old is Sarina Tanimoto?

Dr. Tanimoto is currently 55 years old. There are 5 older executives and no younger executives at ARS Pharmaceuticals. The oldest executive at ARS Pharmaceuticals is Mr. Harris Kaplan M.B.A., Executive Vice President of Commercial Strategy, who is 72 years old. Learn More on Sarina Tanimoto's age.

What is Sarina Tanimoto's salary?

As the Chief Medical Officer of ARS Pharmaceuticals, Inc., Dr. Tanimoto earns $2,470,000.00 per year. The highest earning executive at ARS Pharmaceuticals is Mr. Richard Lowenthal M.B.A., M.S., MSMSEL, Founder, President, CEO & Director, who commands a salary of $2,750,000.00 per year. Learn More on Sarina Tanimoto's salary.

How do I contact Sarina Tanimoto?

The corporate mailing address for Dr. Tanimoto and other ARS Pharmaceuticals executives is 500 Fairview Ave N Suite 600, Seattle WA, 98109. ARS Pharmaceuticals can also be reached via phone at 206-456-2900 and via email at ir@silverbacktx.com. Learn More on Sarina Tanimoto's contact information.

Has Sarina Tanimoto been buying or selling shares of ARS Pharmaceuticals?

Sarina Tanimoto has not been actively trading shares of ARS Pharmaceuticals during the last ninety days. Most recently, Sarina Tanimoto sold 100,000 shares of the business's stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $11.67, for a transaction totalling $1,167,000.00. Following the completion of the sale, the insider now directly owns 1,098,499 shares of the company's stock, valued at $12,819,483.33. Learn More on Sarina Tanimoto's trading history.

Who are ARS Pharmaceuticals' active insiders?

ARS Pharmaceuticals' insider roster includes Justin Chakma (Chief Business Officer), Brian Dorsey (Chief Operating Officer), Alexander Fitzpatrick (Chief Legal Officer), Eric Karas (Chief Commercial Officer), Richard Lowenthal (President and Chief Executive Officer), Kathleen Scott (Chief Financial Officer), Laura Shawver (Director), Sarina Tanimoto (Chief Medical Officer), and Peter Thompson (Director). Learn More on ARS Pharmaceuticals' active insiders.

Are insiders buying or selling shares of ARS Pharmaceuticals?

In the last twelve months, insiders at the sold shares 37 times. They sold a total of 2,961,053 shares worth more than $39,496,274.18. The most recent insider tranaction occured on March, 20th when insider Eric Karas sold 10,000 shares worth more than $140,000.00. Insiders at ARS Pharmaceuticals own 40.1% of the company. Learn More about insider trades at ARS Pharmaceuticals.

Information on this page was last updated on 3/20/2025.

Sarina Tanimoto Insider Trading History at ARS Pharmaceuticals

See Full Table

Sarina Tanimoto Buying and Selling Activity at ARS Pharmaceuticals

This chart shows Sarina Tanimoto's buying and selling at ARS Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$2M$0$2MTotal Insider BuyingTotal Insider Selling

ARS Pharmaceuticals Company Overview

ARS Pharmaceuticals logo
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $12.49
Low: $12.21
High: $12.78

50 Day Range

MA: $12.15
Low: $10.18
High: $14.88

2 Week Range

Now: $12.49
Low: $7.55
High: $18.51

Volume

1,191,077 shs

Average Volume

1,074,219 shs

Market Capitalization

$1.23 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.03